The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.

GS-441524 - Copycat Sci

http://www.ncbi.nlm.nih.gov/pubmed/42455170

Amy Marriott; Andrew Steven; Anja Kipar; James P Stewart; Jessica Dagley; Jesus Reiné; Joseph D Turner; Matthias Mack; Parul Sharma; Shrilakshmi Hegde; Yvette Kazungu

Jul 16, 2026